Srinagar: Two days after Doctors Association of Kashmir (DAK) expressed concern over substandard drugs supplied to hospitals, the association is aghast that more and more drugs supplied by the Jammu and Kashmir Medical Supplies Corporation Limited (JKMSCL) have been found to be substandard.
In a statement issued here, the association appealed doctors to carefully use Amoxycillin capsules (500 mg) and Ceftriazone Injection (1 gm) and Metformin and Glimperide drugs supplied by Jammu and Kashmir Medical Supplies Corporation Limited (JKMSCL) in government hospitals of Kashmir.
The fresh warning came in the backdrop of a “Drug Alert Notice” by the Office of the Controller Drug and Food Control Organization J&K-Jammu for the drugs “Acelofenac-100mg” and “Ceftriazone-1 gm” supplied by JKMSCL.
A few days earlier Amoxycillin capsules (500 mg) and Ceftriazone Injection (1 gm) had been declared “Not of Standard Quality” by Government Analyst, Combined Food and Drug (J&K) Jammu vide no. CFDL/J/2016-17/1179, dated 23/01/2017.
Earlier drugs used for diabetes, Metformin and Glimperide, were also found to be of substandard quality.
DAK said it has always been opposing the government directive of prescribing generic supplied by JKMSCL, who it said seem to be “procuring drugs from some bogus companies”.
Dr Masood Rashid, Senior Executive Member of DAK said that these type of blunders decrease the trust of patients towards doctors.
Dr Mir Mushtaq, Spokesperson, DAK said that in normal procedures the drugs pass through the rigorous quality control measures before being supplied, “but here in our hapless state of Jammu and Kashmir it seems to be other way round”.
“We are appealing to government from last three months over the supplying of substandard medicines in hospital but they don’t pay any attention towards the issue” Dr Mushtaq said.